228 related articles for article (PubMed ID: 17359554)
21. Epstein-Barr virus immune response in high-risk nasopharyngeal carcinoma families in Greenland.
Friborg J; Jarrett RF; Liu MY; Falk KI; Koch A; Olsen OR; Duncan P; Wohlfarht J; Chen JY; Melbye M
J Med Virol; 2007 Dec; 79(12):1877-81. PubMed ID: 17935169
[TBL] [Abstract][Full Text] [Related]
22. The dominance of China 1 in the spectrum of Epstein-Barr virus strains from Cantonese patients with nasopharyngeal carcinoma.
Li DJ; Bei JX; Mai SJ; Xu JF; Chen LZ; Zhang RH; Yu XJ; Hong MH; Zeng YX; Kang T
J Med Virol; 2009 Jul; 81(7):1253-60. PubMed ID: 19475622
[TBL] [Abstract][Full Text] [Related]
23. A prospective evaluation of patients with nasopharyngeal carcinoma: an overview.
Neel HB
J Otolaryngol; 1986 Jun; 15(3):137-44. PubMed ID: 3014165
[TBL] [Abstract][Full Text] [Related]
24. Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation.
Sung MT; Wang M; MacLennan GT; Eble JN; Tan PH; Lopez-Beltran A; Montironi R; Harris JJ; Kuhar M; Cheng L
J Pathol; 2007 Mar; 211(4):420-30. PubMed ID: 17236170
[TBL] [Abstract][Full Text] [Related]
25. [Loss of heterozygosity in the region of chromosome 4p15.1-4q12 in nasopharyngeal carcinoma patients with familial history].
Liu QC; Fang Y; Li XY; Feng QS; Huang LX; Zeng YX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Apr; 24(2):189-91. PubMed ID: 17407079
[TBL] [Abstract][Full Text] [Related]
26. Sensitivity and specificity of Epstein-Barr virus IGA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional review.
Tsang RK; Vlantis AC; Ho RW; Tam JS; To KF; van Hasselt CA
Head Neck; 2004 Jul; 26(7):598-602. PubMed ID: 15229902
[TBL] [Abstract][Full Text] [Related]
27. [Refined mapping of the loss of heterozygosity on chromosome 1q21 in gastric carcinoma].
Liu TF; Yin ZH; Gan RL; Zhao Q; Dong L; Zhou JG; Dong BH
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1229-32. PubMed ID: 18676271
[TBL] [Abstract][Full Text] [Related]
28. [Detailed deletion mapping of chromosome 9p21-22 in nasopharyngeal carcinoma].
Yang J; Tang X; Deng L
Zhonghua Zhong Liu Za Zhi; 1999 Nov; 21(6):419-21. PubMed ID: 11776615
[TBL] [Abstract][Full Text] [Related]
29. [Serologic screening on nasopharyngeal cancer in 338,868 persons in 21 cities and counties of Guangxi Region, China].
Deng H; Zhao Z; Zhang Z
Zhonghua Yu Fang Yi Xue Za Zhi; 1995 Nov; 29(6):342-3. PubMed ID: 8697937
[TBL] [Abstract][Full Text] [Related]
30. Alterations on chromosome 3 in endemic and nonendemic nasopharyngeal carcinoma.
Sung NS; Zeng Y; Raab-Traub N
Int J Cancer; 2000 Apr; 86(2):244-50. PubMed ID: 10738252
[TBL] [Abstract][Full Text] [Related]
31. Plasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma.
Leung SF; Zee B; Ma BB; Hui EP; Mo F; Lai M; Chan KC; Chan LY; Kwan WH; Lo YM; Chan AT
J Clin Oncol; 2006 Dec; 24(34):5414-8. PubMed ID: 17135642
[TBL] [Abstract][Full Text] [Related]
32. [Study of loss of heterozygosity at chromosome 11q13 in nasopharyngeal carcinoma].
Guo Y; Fang Y; Huang B
Zhonghua Zhong Liu Za Zhi; 2001 Mar; 23(2):132-4. PubMed ID: 11783018
[TBL] [Abstract][Full Text] [Related]
33. Expression of matrix metalloproteinase 9 in nasopharyngeal carcinoma and association with Epstein-Barr virus infection.
Tang JG; Li X; Chen P
J Zhejiang Univ Sci; 2004 Oct; 5(10):1304-12. PubMed ID: 15362205
[TBL] [Abstract][Full Text] [Related]
34. [Detailed allelic loss mapping on 7q32 in nasopharyngeal carcinoma].
Tang X; Yang J; Deng L; Jiang N; Zhou M; Zeng Z; Xie Y; Tan G; Qiu Y; Li G
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Jun; 17(3):153-6. PubMed ID: 10837513
[TBL] [Abstract][Full Text] [Related]
35. Loss of heterozygosity of chromosome 16q in gallbladder carcinoma.
Matsuo K; Kuroki T; Kitaoka F; Tajima Y; Kanematsu T
J Surg Res; 2002 Feb; 102(2):133-6. PubMed ID: 11796009
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Epstein-Barr virus antigen-based immunoassays for serological diagnosis of nasopharyngeal carcinoma.
Tang JW; Rohwäder E; Chu IM; Tsang RK; Steinhagen K; Yeung AC; To KF; Chan PK
J Clin Virol; 2007 Dec; 40(4):284-8. PubMed ID: 17977062
[TBL] [Abstract][Full Text] [Related]
37. Direct correlation between FRA3B expression and cigarette smoking.
Stein CK; Glover TW; Palmer JL; Glisson BS
Genes Chromosomes Cancer; 2002 Jul; 34(3):333-40. PubMed ID: 12007194
[TBL] [Abstract][Full Text] [Related]
38. Systemic treatment strategies and therapeutic monitoring for advanced nasopharyngeal carcinoma.
Ma BB; Chan AT
Expert Rev Anticancer Ther; 2006 Mar; 6(3):383-94. PubMed ID: 16503855
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Epstein-Barr virus genotypes and clinicohistopathological features of nasopharyngeal carcinoma between Guilin, China and Fukuoka, Japan.
Zhou Y; Nabeshima K; Koga K; Aoki M; Hayashi H; Hamasaki M; Iwasaki H
Oncol Rep; 2008 Jun; 19(6):1413-20. PubMed ID: 18497945
[TBL] [Abstract][Full Text] [Related]
40. [A specific histological marker of undifferentiated carcinoma of the nasopharynx. The ACIF (Anti-Complement Immunofluorescence) test].
Micheau C; De The G; Schwaab G; Tursz T; Sancho-Garnier H; Montagu B
Ann Pathol; 1984; 4(2):143-6. PubMed ID: 6329239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
